ClinicalTrials.gg
Sign In
RecruitingNCT07786415Updated Nov 10, 2026

Beyond Osteopathic Therapy: Functional Performance Following the Addition of Ujjayi Pranayama in College Students With Upper Cross Syndrome

An interventional study of The experimental group will perform ujjayi pranayama and osteopathic manipulative tratment and control group will perform osteopathic manipulative treatment only in Upper Cross Syndrome, Spinal Alignment and Functional Performance, sponsored by Al-Zaytoonah University of Jordan. Recruiting at 1 site in Egypt. Open to male participants aged 20 Years to 29 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Al-Zaytoonah University of Jordan · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Nov 10, 2026Now RecruitingFirst site in Egypt+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
20 Years to 29 Years
Sex
Male
01

Study summary

This study aims to explore the relationship between spinal alignment and functional performance in individuals with upper cross syndrome following a combined breathing and manual therapy program. It is designed as a secondary analysis of data obtained from a previously conducted randomized controlled trial, with the addition of objective spinal measurements using the Spinal Mouse device. Functional performance will be assessed using standardized tests such as the 6-minute walk test and the timed up and go test. Statistical analysis will include correlation and regression models to determine whether spinal alignment parameters can predict functional outcomes. The findings are expected to provide insight into the biomechanical role of posture in functional recovery among individuals with upper cross syndrome.

02

Conditions studied

  • Upper Cross Syndrome
  • Spinal Alignment
  • Functional Performance

Keywords

  • upper cross syndrome
  • Spinal alignment
  • Functional performance
03

In context

Lead sponsor

Al-Zaytoonah University of Jordan is the lead sponsor of 31 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 29 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Full time college students of age 20-29 years.

    • Subjects who have upper cross syndrome according to REEDCO posture assessment.
    • Subjects who not receiving medical treatment for respiratory diseases .
    • Subjects who have clean family medical history.

Exclusion criteria

Exclusion Criteria:

  • Subjects who engaged in additional exercise in two weeks, which was likely to affect the results of the research .
  • Individuals with a history of spine, shoulder fractures, surgery, or other disease.
  • Individuals with severe cardia-cerebrovascular disease.
  • Individuals who will have difficulty to follow-up testing).
  • Neurologic and psychiatric disorders (who can not understand the research project ).
  • Individuals with congenital deformities
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Experimental group

    Other: The experimental group will perform ujjayi pranayama and osteopathic manipulative tratment

  • Active comparator
    Control group

    Other: control group will perform osteopathic manipulative treatment only

Interventions

  • OtherThe experimental group will perform ujjayi pranayama and osteopathic manipulative tratment

    The experimental group will perform ujjayi pranayama and osteopathic manipulative treatment for 45 min sessions, 5 times a week for 8 weeks

  • Othercontrol group will perform osteopathic manipulative treatment only

    control group will perform osteopathic manipulative treatment only for 45 min sessions, 5 times a week for 8 weeks

06

What researchers measure

Primary outcomes

  1. Spinal Alignment: Thoracic kyphosis

    Kyphosis is the forward curvature of the thoracic spine.It will be measured by The Spinal Mouse ( a hand-held, computer-assisted medical device used to measure spinal curvature, posture, and segmental mobility without radiation )

    Time frame: Pre and post 8 weeks

  2. Spinal Alignment: Lumbar lordosis

    inward curvature of the spine when this curve becomes excessive or diminished, it can lead to discomfort and postural issues.It will be measured by The Spinal Mouse ( a hand-held, computer-assisted medical device used to measure spinal curvature, posture, and segmental mobility without radiation )

    Time frame: Pre and post 8 weeks

Secondary outcomes

  1. Functional Performance: 6-Minute Walk Test (6MWT)

    a clinical exercise test that measures the total distance an individual can walk on a flat, hard surface over a period of 6 minutes

    Time frame: Pre and post 8 weeks

  2. Functional Performance: Timed Up and Go Test (TUG)

    measures functional mobility and fall risk. It records the seconds it takes a person to stand up from a standard armchair, walk 3 meters (10 feet), turn around, walk back, and sit down again

    Time frame: Pre and post 8 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Aug 2026 to primary completion in Oct 2026, 2 months.

Completion moved once since we started tracking on Sep 25, 2026: Oct 2026 → Nov 2026, on Nov 10, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2026
First posted
Aug 26, 2026
StartActual
Aug 25, 2026
Primary completionActual
Oct 25, 2026
CompletionEst.
Nov 15, 2026was Oct 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 9, 2026
Sites
1 site added — first site in Egypt
Show site
  • Mohamed Saied Zidan · Cairo, Egypt
Oct 9, 2026
Study completion
Oct 25, 2026→Nov 15, 2026
Nov 10, 2026
Title
Spinal Alignment as a Predictor of Functional Performance in Individuals With Upper Cross Syndrome: A Secondary Analysis of a Randomized Controlled Trial→Beyond Osteopathic Therapy: Functional Performance Following the Addition of Ujjayi Pranayama in College Students With Upper Cross Syndrome
across 2 updates, Oct 9, 2026 – Oct 16, 2026
Show all 3 updates
  1. Nov 10, 2026
    Study completion Oct 25, 2026→Nov 15, 2026
    + 1 other change: verification date
  2. Oct 16, 2026
    Title Beyond ManualOsteopathic Therapy: Functional Performance Following the Addition of Ujjayi Pranayama in College Students With Upper Cross Syndrome
  3. Oct 9, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in Egypt
    Show site
    • Mohamed Saied Zidan · Cairo, Egypt
    Title Spinal Alignment as a Predictor of Functional Performance in Individuals With Upper Cross Syndrome: A Secondary Analysis of a Randomized Controlled Trial→Beyond Manual Therapy: Functional Performance Following the Addition of Ujjayi Pranayama in College Students With Upper Cross Syndrome
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07786415
Lead sponsor
Al-Zaytoonah University of Jordan
Responsible party
Mohamed Saied Zidan (assistant professor doctor, Al-Zaytoonah University of Jordan) — Principal investigator
First posted
Aug 26, 2026
Start date
Aug 25, 2026
Primary completion
Oct 25, 2026
Completion
Nov 15, 2026 (estimated)
Last update
Nov 10, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Oculocerebral hypopigmentation syndrome type Preus

Other studies from this sponsor

Al-Zaytoonah University of Jordan

Start the discussion